SGLT-2 inhibitor for treating type 1 diabetes mellitus, type 2 diabete mellitus, impaired glucose tolerance or hyperglycemia
Details for Australian Patent Application No. 2010212865 (hide)
International Classifications
Event Publications
21 July 2011 PCT application entered the National Phase
PCT publication WO2010/092123 Priority application(s): WO2010/092123
17 November 2011 Corrigenda
PCT applications that have entered the National Phase - Name Index Under the name Boehringer Ingelheim International GmbH, Application No. 2010212865, under INID (54) correct the title to read SGLT-2 inhibitor for treating type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance or hyperglycemia
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser